University of California San Francisco
Give to UCSF
The Howard Hughes Medical Institute (HHMI) has awarded three fellowships to UCSF medical students to allow them to conduct research for a full year in between their third and fourth years of medical school.
UCSF is starting a campus-wide bioethics program led by the noted bioethics scholar Barbara Koenig to ensure that the rapid advances in biomedical technology are incorporated ethically into research and medicine.
UCSF surgeons performed the first Osseoanchored Prosthesis for the Rehabilitation of Amputees surgery in the U.S. – a surgery that will allow an external prosthesis to be anchored directly to the patient’s remaining bone.
A 27-year-old drug for anemia may protect newborns at high risk for brain damage, according to the results of a multisite trial led by researchers at UCSF.
UCSF has created a new, need-based Cost of Living Supplement pilot program for students to help offset the high cost of housing in the city.
UCSF's Discovery Fellows Program once again exceeded its goals in a second round of fundraising, with a total of 1,042 donors building an endowment of $80 million to support basic science education and research for generations to come.
Andrew Bindman has been named director of the U.S. Agency for Healthcare Research and Quality.
Proper communication between the left and right sides of the brain is critical for the development of advanced language skills, according to new research by UC San Francisco scientists.
Five UCSF faculty members have been elected to the American Society for Clinical Investigation after a highly competitive nomination process.
Refugees who fled to Europe a generation ago are significantly more likely to have developed type 2 diabetes if they initially settled in poor neighborhoods, according to a study of 60,000 refugees who came to Sweden between 1987 and 1991.
Exciting advances in medicine and health are being researched in precision medicine projects recently funded by the George and Judy Marcus Program in Precision Medicine Innovation.
New research by UCSF scientists could accelerate – by 10 to 100-fold – the pace of many efforts to profile gene activity, ranging from basic research into how to build new tissues from stem cells to clinical efforts to detect cancer or auto-immune diseases by profiling single cells in a tiny drop of blood.
The ninth annual Chancellor’s Diversity Forum provided a chance for UCSF faculty, staff and students to engage in a conversation with campus leadership about diversity, equity and inclusion across the University.
In the largest-ever gift to UCSF, the Weill Family Foundation and Joan and Sanford I. “Sandy” Weill have donated $185 million to establish the UCSF Weill Institute for Neurosciences.
UCSF leaders are lauding the gift by Joan and Sanford I. Weill as transformational, giving the University an unprecedented opportunity to unite and expand its neurosciences community during a revolutionary period in brain discovery.
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
Stem cell biologists at UCSF have demonstrated that IL-1 itself directly transforms the blood system by driving blood stem cells in the bone marrow to switch away from their restorative, rejuvenating role in blood renewal and towards emergency production of immune cells.
Global malaria eradication is possible within a generation, but only with renewed focus, new tools and sufficient financial support, according to a paper published in The Lancet by the Global Health Group’s Malaria Elimination Initiative at UCSF.
Time magazine has named internationally renowned breast cancer oncologist Laura Esserman to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.
Frontotemporal dementia, the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
Graduate students Nairi Hartooni and Lindsey Osimiri have been named as recipients of the Paul & Daisy Soros Fellowship for New Americans.
UCSF neuroscientists Michael Brainard and John L.R. Rubenstein have been elected to the American Academy of Arts and Sciences.
The new UCSF Center for BRCA Research – which spans basic and translational research, clinical care and education – provides a one-stop resource for patients and individuals who carry BRCA1 and BRCA2 mutations.
UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.